Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 1,807 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Implanted Device Clear all

Conditions: Patent Foramen Ovale, Cryptogenic Stroke
Interventions: Encore PFO closure device, FDA-approved PFO closure device; Device
Lead sponsor: Encore Medical Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 8
States / cities: Little Rock, Arkansas • La Jolla, California • Tampa, Florida + 5 more

Conditions: Heart Failure, Indications for Lead Removal
Interventions: LV Lead Extraction; Procedure
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 21
States / cities: Phoenix, Arizona • Burbank, California • Long Beach, California + 18 more

Conditions: Overactive Bladder
Interventions: Intermittent or Continuous Setting RestorePrime Implanted Impulse Generator; Device
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Fecal Incontinence
Interventions: TOPAS Treatment for Fecal Incontinence; Device
Lead sponsor: ASTORA Women's Health; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 207 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 14
States / cities: San Francisco, California • Tampa, Florida • Weston, Florida + 11 more

Conditions: Tourette Syndrome
Interventions: Continuous DBS, Responsive Brain Stimulation (RBS Setting); Device
Lead sponsor: University of Florida; Other
Eligibility: 21 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Hysterectomy
Interventions: Hysteroscopic device placement including Essure (ESS305, BAY1454032), Tubal ligation; Device · Procedure
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 10,578 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: New Jersey, New Jersey

Conditions: Peri-implant Mucositis
Interventions: Water Flosser, Manual Toothbrush; Device
Lead sponsor: Water Pik, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Overactive Bladder
Interventions: Not listed
Lead sponsor: Michael Chancellor, MD; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Sick Sinus Syndrome, Complete Heart Block, Syncope, Chronic Systolic Heart Failure
Interventions: polymixin/bacitracin, cephalexin, or levofloxacin, or clindamycin, Saline; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,010 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: End Stage Renal Disease
Interventions: Xeltis Hemodialysis Access (aXess) graft; Device
Lead sponsor: Xeltis; Industry
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2032
U.S. locations: 7
States / cities: Phoenix, Arizona • Tuscon, Arizona • Sarasota, Florida + 4 more

Conditions: Essential Tremor
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Congenital Heart Defects, Dysfunctional Right Ventricular Outflow Tract Conduits
Interventions: Transcatheter Pulmonary Valve replacement; Device
Lead sponsor: Medtronic Cardiovascular; Industry
Eligibility: 5 Years and older
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2020
U.S. locations: 5
States / cities: Miami, Florida • Boston, Massachusetts • New York, New York + 2 more

Conditions: Stroke, Complication, Stroke, Stroke Sequelae, Hemiparesis, Arm Paralysis
Interventions: Cortimo; Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Central Sleep Apnea
Interventions: remede System; Device
Lead sponsor: Respicardia, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2030
U.S. locations: 29
States / cities: Phoenix, Arizona • Scottsdale, Arizona • San Francisco, California + 24 more

Conditions: Refractory Angina
Interventions: Arm 1: treatment with Shockwave Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry; Device · Other
Lead sponsor: Shockwave Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 72
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 57 more

Conditions: Stage D Heart Failure
Interventions: Sacubitril-Valsartan, Usual care (standard-of-care) arm; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cardiogenic Shock
Interventions: Impella-CP LV Vent; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pulmonary Embolism
Interventions: Inferior Vena Cava Filter; Device
Lead sponsor: Crux Biomedical; Industry
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 17
States / cities: Orange, California • Sacramento, California • Newark, Delaware + 13 more

Conditions: Chronic Heart Failure
Interventions: HeartWare Ventricular Assist Device; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 33
States / cities: Little Rock, Arkansas • San Diego, California • San Francisco, California + 25 more

Conditions: Pancreatic Cancer
Interventions: Device Arm with Therapeutic Agents; Combination Product
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Coronary Artery Disease
Interventions: Coronary PCI with OCT with Co Registration, Coronary PCI with OCT without Co Registration; Procedure
Lead sponsor: St. Francis Hospital, New York; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Roslyn, New York

Conditions: Spinal Cord Injury, Paralysis, Tetraplegia, Paraplegia
Interventions: IST-16 (16-Channel implanted stimulator-telemeter; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Open Angle Glaucoma, Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma, Pigmentary Glaucoma
Interventions: Hydrus Microstent, Ophthalmic surgery; Device · Procedure
Lead sponsor: Alcon Research; Industry
Eligibility: 45 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 5
States / cities: Bentonville, Arkansas • Zephyrhills, Florida • Fraser, Michigan + 2 more

Conditions: Cardiogenic Shock, Heart Failure, Ambulatory Hemodynamic Monitoring
Interventions: CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization; Device
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Falls Church, Virginia

Search by objective public record fields.

Encore PFO Closure Device - The PerFOrm Trial

Attain StarFix® 4195 Lead Extraction Study

Neuromodulation Implantation Settings Variation for Overactive Bladder

Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence

Tourette Syndrome Deep Brain Stimulation

Proportion of Hysterectomy After Female Sterilization

Efficacy of an Oral Hygiene Implant Protocol

Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.

Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.

Xeltis Hemodialysis Access Graft (aXess) US Study

Deep Brain Stimulation Effects in Essential Tremor

Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort

Neuromotor Prosthetic to Treat Stroke-Related Paresis

remedē System Therapy Study

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

Impella CP With VA ECMO for Cardiogenic Shock

Crux Biomedical Vena Cava Filter Study - United States

Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer

Does Co-registration of OCT and Angiography Reduce Geographic Miss of Stent Implantation?

A Neuroprosthesis for Prolonged Standing After SCI Using Multi-Contact Peripheral Nerve Electrodes

Safety and Effectiveness of the Hydrus Microstent

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial